Kathrine O'Brien Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Kathrine O'Brien.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Kathrine O'Brien. Kathrine O'Brien is a Director in AMAG PHARMACEUTICALS INC. ($AVM) and a Director in Tabula Rasa HealthCare, Inc. ($TRHC).

Address: 228 STRAWBRIDGE DRIVE SUITE 100 MOORESTOWN 08057 NJ

Companies in which Kathrine O'Brien is an Insider

AMAG PHARMACEUTICALS, INC.

Trading Symbol: AVM
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Kathrine O'Brien: Director
Holdings: 0 shares
Latest Transaction: Nov 17 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Tabula Rasa HealthCare, Inc.

Trading Symbol: TRHC
Industry: SERVICES-BUSINESS SERVICES, NEC [7389]
Position of Kathrine O'Brien: Director
Holdings: 17,671 shares
Current Value: $277,435
Latest Transaction: Jun 14 2021
$TRHC Market Capitalization: $255.52M
$TRHC Previous Close: $15.70

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Kathrine O'Brien

Sentiment: All, AVM, TRHC

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 14 2021TRHCTabula Rasa Health ...O'Brien KathrineDirectorGrantA0.003,792017,67113.9 K to 17.7 K (+27.32 %)
Nov 17 2020AVMAMAG PHARMACEUTICA ...O'Brien KathrineDirectorOption ExerciseD0.0021,28900
Nov 17 2020AVMAMAG PHARMACEUTICA ...O'Brien KathrineDirectorOption ExerciseD0.0017,32600
Nov 17 2020AVMAMAG PHARMACEUTICA ...O'Brien KathrineDirectorOption ExerciseD0.001,20000
Nov 17 2020AVMAMAG PHARMACEUTICA ...O'Brien KathrineDirectorOption ExerciseD0.006,00000
Nov 17 2020AVMAMAG PHARMACEUTICA ...O'Brien KathrineDirectorSellD0.0018,9490018.9 K to 0 (-100.00 %)
Nov 17 2020AVMAMAG PHARMACEUTICA ...O'Brien KathrineDirectorOption ExerciseD0.0021,28900

View all Kathrine O'Brien insider transactions.